This post explains how AI-enabled qualitative research methods can clarify veterinarian pharmacist collaboration and speed evidence synthesis for researchers and clinical teams. The primary keyword is veterinarian pharmacist collaboration, and this post uses the PLOS One scoping review as the empirical anchor. The goal is to show which qualitative signals matter (roles, barriers, regional patterns), how the PLOS One data can be turned into actionable insights, and how AI tools accelerate thematic coding, cross-segment counts, and reproducible reporting.
Key Takeaways
According to the PLOS One scoping review “Veterinarian–pharmacist collaboration in veterinary medicine: Roles, practices, and perceptions; A scoping review” (Kambayashi et al., published July 31, 2026), the literature retrieved 239 records and synthesized 16 studies, showing a concentrated but varied evidence base.
- The review retrieved 239 records and, after screening, included 16 studies published between 2007 and 2024 (search completed 30 August 2025), according to Kambayashi et al. (PLOS One, July 31, 2026).
- Compounding and dispensing were the most frequently reported pharmacist roles, appearing in 62.5% (10 of 16) of included studies, according to Kambayashi et al. (PLOS One, July 31, 2026).
- Drug information and consultation appeared in 37.5% (6 of 16) of studies, and inventory or supply management appeared in 25.0% (4 of 16) of studies, according to Kambayashi et al. (PLOS One, July 31, 2026).
- Kambayashi et al. (PLOS One, July 31, 2026) conclude that “Pharmacists are expanding their participation in veterinary healthcare teams, ” and that addressing training gaps through veterinary-specific education is essential to deeper integration.
What Happened: PLOS One scoping review findings
A scoping review published in PLOS One on July 31, 2026, mapped the peer-reviewed and gray literature on veterinarian pharmacist collaboration and identified patterns of roles, settings, and perceived barriers (Kambayashi et al., PLOS One, July 31, 2026).
Kambayashi et al. (PLOS One, July 31, 2026) searched PubMed, Web of Science, the Cochrane Library, Ichushi-Web, and Google Scholar through 30 August 2025 and screened 239 records to include 16 eligible studies published between 2007 and 2024.
Kambayashi et al. (PLOS One, July 31, 2026) reported that most included studies used cross-sectional survey methods and that study locations clustered in the United States (n = 7), New Zealand (n = 3), and Japan (n = 3).
Kambayashi et al. (PLOS One, July 31, 2026) summarize the dominant pharmacist activities as compounding/dispensing (62.5%, 10 of 16), drug information and consultation (37.5%, 6 of 16), inventory/supply management (25.0%, 4 of 16), client education (18.8%, 3 of 16), and safety/exposure control (12.5%, 2 of 16).
Kambayashi et al. (PLOS One, July 31, 2026) identify a recurring barrier: veterinarians’ concern about pharmacists’ limited training in species-specific physiology, which constrains clinical-level collaboration.
Kambayashi et al. (PLOS One, July 31, 2026) warn that most evidence is perception-based and that higher-quality quantitative studies are needed to measure clinical or safety outcomes of pharmacist integration.
Findings Snapshot
| Date / Source | Metric | Value | Implication |
|---|---|---|---|
| 30 August 2025 / PLOS One (search end) | Records retrieved | 239 | Large initial pool; heavy screening required to find empirical studies |
| July 31, 2026 / PLOS One (publication) | Studies included | 16 (published 2007–2024) | Evidence base is small and heterogeneous |
| Kambayashi et al., PLOS One (2026) | Compounding/dispensing | 62.5% (10 of 16 studies) | Technical compounding is the most common pharmacist contribution |
| Kambayashi et al., PLOS One (2026) | Drug information and consultation | 37.5% (6 of 16 studies) | Advisory roles exist but are less common than compounding |
| Kambayashi et al., PLOS One (2026) | Geographic spread | US 7, NZ 3, Japan 3, others | Regional models vary; non-English evidence (Japan) is influential |
Implications for veterinary researchers and education leads
The PLOS One review implies that qualitative research and mixed-methods studies are needed to move beyond perception surveys and measure outcomes, according to Kambayashi et al. (PLOS One, July 31, 2026).
- Design: Use multi-site, mixed-methods designs to capture both clinical outcomes and professional perceptions; Kambayashi et al. (PLOS One, July 31, 2026) note most current studies are cross-sectional.
- Education: Invest in veterinary-specific pharmacy curricula and experiential placements; Kambayashi et al. (PLOS One, July 31, 2026) state that specialized education is “a critical step” toward integration.
- Translation: Include non-English databases and apply machine translation when feasible; Kambayashi et al. (PLOS One, July 31, 2026) found key Japanese studies that would be missed without Ichushi-Web searches.
For policy and guideline developers, Kambayashi et al. (PLOS One, July 31, 2026) recommend establishing standardized veterinary dispensing guidelines before scaling clinical pharmacist roles.
How Evidano Helps: problem → AI-enabled solution mappings
Problem: Fragmented, perception-based evidence
Solution: Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.
Evidano can ingest the PLOS One review corpus, extract coded themes, and produce frequency and co-occurrence analyses to quantify how often roles and barriers appear across studies.
Problem: Manual synthesis of cross-study themes is slow
Solution: Evidano’s thematic and cross-segment analyses automatically cluster concepts (for example, compounding, drug information, inventory) and show which regions or settings report each role most often; users can export reproducible tables and visualizations to speed reporting.
For methods transparency, Evidano preserves source links and extracts quotations to support claims, helping researchers comply with reporting standards.
Problem: Non-English evidence is hard to surface
Solution: Evidano’s document ingestion plus translation workflow (see translation features) helps teams translate non-English abstracts and include Ichushi-Web outputs in syntheses without losing coding fidelity.
This reduces the language bias that Kambayashi et al. (PLOS One, July 31, 2026) identify as a limitation in global reviews.
Problem: Need for rapid stakeholder-ready outputs
Solution: Evidano produces ready visuals (word clouds, co-occurrence networks, hierarchical code maps) and supports AI chat over your documents to generate executive summaries and evidence tables in minutes; see Evidano features.
These outputs let education leads and clinical managers iterate interventions (curriculum modules, pharmacy externships) and track which components the literature supports.
FAQ: veterinarian pharmacist collaboration qualitative analysis
What are the main pharmacist roles reported in the PLOS One scoping review?
+
Answer: The main roles are compounding/dispensing, drug information/consultation, inventory and supply management, client education, and safety/exposure control.
Kambayashi et al. (PLOS One, July 31, 2026) report compounding/dispensing in 62.5% (10 of 16) of studies and drug information/consultation in 37.5% (6 of 16).
How strong is the evidence that pharmacists improve clinical outcomes in veterinary settings?
+
Answer: Current evidence is weak on direct clinical outcomes because most studies are perception-based cross-sectional surveys.
Kambayashi et al. (PLOS One, July 31, 2026) note a lack of quantitative outcome studies and recommend future research to measure therapeutic adherence, adverse events, and safety metrics.
Can AI tools help synthesize perception-based surveys into usable recommendations?
+
Answer: Yes, AI-enabled qualitative analysis can standardize coding, quantify theme frequencies, and surface representative quotations to support recommendations.
Using the PLOS One review as an example, an AI pipeline can extract the 16 included studies, tag roles and barriers, and produce cross-tabulations by country and setting for faster policy drafting.
What practical steps should education programs take to prepare pharmacists for veterinary collaboration?
+
Answer: Programs should add veterinary-specific pharmacology modules, create externships in veterinary hospitals, and offer interprofessional activities linking pharmacy and veterinary students.
Kambayashi et al. (PLOS One, July 31, 2026) and several referenced studies recommend residencies and experiential placements as pathways to professional trust.
Conclusion & Next Steps
The PLOS One scoping review (Kambayashi et al., published July 31, 2026) shows a small but growing literature where pharmacists most often support compounding and drug information, and where species-specific training remains a key barrier to deeper clinical integration.
AI-enabled qualitative research methods can convert the 239-record screening funnel and the 16 included studies into reproducible thematic maps, frequency tables, and stakeholder-ready summaries to inform curricula and pilot collaborations.
Evidano supports these workflows through document ingestion, thematic and cross-segment analysis, translation, and visualization; learn more at Evidano features.
To try this approach on your review or dataset, Try Evidano for free.
Topics
- veterinarian pharmacist collaboration
- veterinary pharmacist collaboration
- AI qualitative analysis
- qualitative synthesis veterinary
Keep reading
- Commentary on NewsPractical Guide: Veterinarian Pharmacist CollaborationAI qualitative analysis of veterinarian pharmacist collaboration: key findings from a PLOS ONE scoping review and steps to speed thematic synthesis with Evidano.
- Commentary on NewsFrom Interviews to Insight: AI Qualitative AnalysisLearn how AI qualitative analysis can organize mental health interviews, compare stakeholder views, and support culturally aware research. Try Evidano.
- Commentary on NewsWhat ELLY Reveals About AI Qualitative AnalysisSee how AI qualitative analysis can turn community-health interviews into defensible themes, pathways, and decisions, using findings from the 2026 ELLY study.